Literature DB >> 9205831

Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial.

S J Evans, P C Waller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9205831

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine.

Authors:  I D Lightbown; J P Lambert; G Edwards; S J Coker
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  The antimalarial agent mefloquine inhibits ATP-sensitive K-channels.

Authors:  F M Gribble; T M Davis; C E Higham; A Clark; F M Ashcroft
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.